1-5 of 5
Masayuki Hino, MDPhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

The Proportional Association between WT1 mRNA Level in Peripheral Blood before Allogeneic Hematopoietic Cell Transplantation and Risk of Mortality in Acute Myeloid Leukemia Not in Remission

Kentaro Ido, MD, Mika Nakamae, MDPhD, Hideo Koh, MDPhD, Hiroshi Okamura, Satoru Nanno, MD PhD, Mitsutaka Nishimoto, MDPhD, Yoshinori Hashimoto, MD, Yasunobu Takeoka, MDPhD, Asao Hirose, MDPhD, Yasuhiro Nakashima, MDPhD, Takahiko Nakane, MD PhD, Masayuki Hino, MDPhD, Hirohisa Nakamae, MDPhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 4665.
https://doi.org/10.1182/blood-2018-99-111834
Published: 2018
Journal Articles

Long-Term Efficacy and Safety (5 Years) in RESPONSE, a Phase 3 Study Comparing Ruxolitinib (rux) with Best Available Therapy (BAT) in Hydroxyurea (HU)-Resistant/Intolerant Patients (pts) with Polycythemia Vera (PV)

Jean-Jacques Kiladjian, MD PhD, Pierre Zachée, Masayuki Hino, MDPhD, Fabrizio Pane, Tamas Masszi, MD Prof., Claire N. Harrison, MD DM, FRCP, PRCPath, Ruben A. Mesa, MD, Carole B. Miller, MD, Francesco Passamonti, MD, Simon Durrant, FRCP,FRCPath,MBBS, Martin Griesshammer, MD PhD, Keita Kirito, MD, Carles Besses, MD PhD, Beatriz Moiraghi, Elisa Rumi, MD, Vittorio Rosti, MD, Igor W. Blau, Nathalie Francillard, Tuochuan Dong, Monika Wroclawska, MD, Alessandro M. Vannucchi, MD, Srdan Verstovsek, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1753.
https://doi.org/10.1182/blood-2018-99-115129
Published: 2018
Journal Articles

Results from the 208-Week (4-Year) Follow-up of RESPONSE Trial, a Phase 3 Study Comparing Ruxolitinib (Rux) with Best Available Therapy (BAT) for the Treatment of Polycythemia Vera (PV)

Jean-Jacques Kiladjian, MD PhD, Srdan Verstovsek, MD PhD, Martin Griesshammer, Tamás Masszi, MD Prof., Simon Durrant, FRCP,FRCPath,MBBS, Francesco Passamonti, MD, Claire N. Harrison, BMBCh, DM, FRCP, FRCPath, Fabrizio Pane, MD, Pierre Zachee, MD PhD, Keita Kirito, MD, Carlos Besses, MD PhD, Masayuki Hino, MDPhD, Ana Ines Varela, Carole B. Miller, MD, Elisa Rumi, MD, Vittorio Rosti, MD, Igor Wolfgang Blau, MD, Ruben A Mesa, MD, Tuochuan Dong, Nathalie Francillard, Mary Laughlin, Alessandro M. Vannucchi
Journal: Blood
Blood (2017) 130 (Supplement 1): 322.
https://doi.org/10.1182/blood.V130.Suppl_1.322.322
Published: 2017
Journal Articles

Pre-Transplant Transferrin Saturation Levels As a Predictive Marker for Invasive Fungal Disease Following Allogeneic Hematopoietic Stem Cell Transplantation

Satoru Nanno, MDPhD, Hideo Koh, MDPhD, Mitsutaka Nishimoto, MDPhD, Takahiko Nakane, MDPhD, Yasuhiro Nakashima, MDPhD, Yasunobu Takeoka, MDPhD, Mika Nakamae, MDPhD, Asao Hirose, MDPhD, Masayuki Hino, MDPhD, Hirohisa Nakamae, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1965.
https://doi.org/10.1182/blood.V130.Suppl_1.1965.1965
Published: 2017
Journal Articles

Post-Transplant Cyclophosphamide Contributes to Impaired Graft-Versus-Leukemia Effects and Regulates Graft-Versus-Host Disease in the Murine Stem Cell Transplant Model

Yosuke Makuuchi, MD, Yasuhiro Nakashima, MDPhD, Hideo Koh, MDPhD, Takahiko Nakane, MDPhD, Hirohisa Nakamae, MDPhD, Masayuki Hino, MDPhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 4448.
https://doi.org/10.1182/blood.V130.Suppl_1.4448.4448
Published: 2017